Rekord LOINC: 101583-3
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
101583-3
FHIR
|
| Long Common Name: | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative |
| Short Name: | ESBL cft to cft-clav IC rto Bd Pos Imp |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
:
Imp
:
Pt
:
Bld.pos growth
:
Ord
:
Based on lab data
Klasyfikacja
| Class: |
ENABXBACT
|
| Consumer Name: | - |
| Order/Observation: | Both |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | N |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.75 |
Powiązane nazwy
ANTIBIOTIC SUSCEPTIBILITIES; B; Betalactamase; B-Lactamase; Bld Pos; Blood; c305; Ceftaz; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ESBL by ceftaz to ceft-clav IC rto; Forj; Fortaz; from lab data; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tazicef; Tazj; WB; Whole blood